Steven Feldman to Interleukin-23 Subunit p19
This is a "connection" page, showing publications Steven Feldman has written about Interleukin-23 Subunit p19.
Connection Strength
1.328
-
Li W, Ghamrawi R, Haidari W, Feldman SR. Risankizumab for the Treatment of Moderate to Severe Plaque Psoriasis. Ann Pharmacother. 2020 04; 54(4):380-387.
Score: 0.688
-
Kolli SS, Gabros SD, Pona A, Cline A, Feldman SR. Tildrakizumab: A Review of Phase II and III Clinical Trials. Ann Pharmacother. 2019 04; 53(4):413-418.
Score: 0.641